Arbutus Biopharma logo

Arbutus Biopharma Share Price Today (NASDAQ: ABUS)

Arbutus Biopharma share price is $3.53 & ₹303.81 as on 14 Jun 2025, 01.29 hrs IST

$3.53

-0.05

(-1.4%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Arbutus Biopharma share price in Dollar and Rupees. Guide to invest in Arbutus Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arbutus Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Arbutus Biopharma share price movements

  • Today's Low: $3.50
    Today's High: $3.58

    Day's Volatility :2.37%

  • 52 Weeks Low: $2.71
    52 Weeks High: $4.73

    52 Weeks Volatility :42.75%

Arbutus Biopharma (ABUS) Returns

PeriodArbutus Biopharma CorporationSector (Health Care)Index (Russel 2000)
3 Months
7.62%
-6.1%
0.0%
6 Months
-0.56%
-3.4%
0.0%
1 Year
12.42%
-6.7%
0.0%
3 Years
38.43%
13.0%
3.6%

Arbutus Biopharma (ABUS) Key Statistics

in dollars & INR

Previous Close
$3.58
Open
$3.58
Today's High
$3.58
Today's Low
$3.495
Market Capitalization
$670.3M
Today's Volume
$515.4K
52 Week High
$4.725
52 Week Low
$2.705
Revenue TTM
$6.4M
EBITDA
$-66.2M
Earnings Per Share (EPS)
$-0.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-79.02%

How to invest in Arbutus Biopharma Stock (ABUS) from India?

It is very easy for Indian residents to invest directly in Arbutus Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arbutus Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arbutus Biopharma or ABUS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arbutus Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arbutus Biopharma shares which would translate to 0.244 fractional shares of Arbutus Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Arbutus Biopharma, in just a few clicks!

Returns in Arbutus Biopharma (ABUS) for Indian investors in Rupees

The Arbutus Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arbutus Biopharma investment value today

Current value as on today

₹1,15,459

Returns

₹15,459

(+15.46%)

Returns from Arbutus Biopharma Stock

₹12,420 (+12.42%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Arbutus Biopharma (ABUS)

-60%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Search interest for Arbutus Biopharma Stock from India on INDmoney has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Arbutus Biopharma

  • Morgan Stanley - Brokerage Accounts

    12.42%

  • Whitefort Capital Management, LP.

    6.95%

  • BlackRock Inc

    6.67%

  • Two Seas Capital LP

    4.94%

  • Vanguard Group Inc

    4.68%

  • State Street Corp

    2.28%

Analyst Recommendation on Arbutus Biopharma

Rating
Trend

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Arbutus Biopharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Arbutus Biopharma Stock (ABUS)

What analysts predicted

Upside of 52.22%

Target:

$5.37

Current:

$3.53

Insights on Arbutus Biopharma Stock (Ticker Symbol: ABUS)

  • Price Movement

    In the last 1 month, ABUS stock has moved up by 11.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.33M → 1.76M (in $), with an average increase of 12.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -12.53M → -24.52M (in $), with an average decrease of 95.7% per quarter
  • ABUS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 79.3%
  • ABUS vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.3% return, outperforming this stock by 85.0%
  • Price to Sales

    ForABUS every $1 of sales, investors are willing to pay $103.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Arbutus Biopharma Technicals Summary

Sell

Neutral

Buy

Arbutus Biopharma is currently in a neutral trading position according to technical analysis indicators.

Arbutus Biopharma (ABUS) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Arbutus Biopharma Corporation logo
13.14%
-0.56%
12.42%
38.43%
91.85%
Regeneron Pharmaceuticals, Inc. logo
-9.61%
-27.05%
-48.98%
-5.77%
-10.46%
Beone Medicines Ltd logo
19.44%
52.93%
65.87%
97.21%
57.25%
Vertex Pharmaceuticals Incorporated logo
4.88%
-2.68%
-5.24%
79.7%
70.13%
Alnylam Pharmaceuticals, Inc. logo
8.48%
26.01%
91.68%
126.98%
139.48%

About Arbutus Biopharma

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Organization
Arbutus Biopharma
Employees
44
CEO
Ms. Lindsay Androski J.D., M.B.A.
Industry
Health Technology

Management People of Arbutus Biopharma

NameTitle
Ms. Lindsay Androski J.D., M.B.A.
President, CEO & Chairman
Mr. Tuan Nguyen
Chief Financial Officer
Mr. Andrew J. Sung
General Counsel
Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C.
Corporate Secretary

Important FAQs about investing in ABUS Stock from India :

Can Indians buy Arbutus Biopharma shares?

Yes, Indians can invest in the Arbutus Biopharma (ABUS) from India.

With INDmoney, you can buy Arbutus Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Arbutus Biopharma at zero transaction cost.

How can I buy Arbutus Biopharma shares from India?

It is very easy to buy Arbutus Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arbutus Biopharma (ABUS) be purchased?

Yes, you can buy fractional shares of Arbutus Biopharma with INDmoney app.

What are the documents required to start investing in Arbutus Biopharma stocks?

To start investing in Arbutus Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Arbutus Biopharma share price today?

Arbutus Biopharma share price today stands at $3.53, Open: $3.58 ; Previous Close: $3.58 ; High: $3.58 ; Low: $3.50 ; 52 Week High: $4.73 ; 52 Week Low: $2.71.

The stock opens at $3.58, after a closing price of $3.58. The stock reached a daily high of $3.58 and a low of $3.50, with a 52-week high of $4.73 and a 52-week low of $2.71.

What are today’s High and Low prices of Arbutus Biopharma Stock (ABUS)?

Today’s highest price of Arbutus Biopharma (ABUS) is $3.58.

Today’s lowest price of Arbutus Biopharma (ABUS) is $3.50.

What is the 52 Week High and Low Range of Arbutus Biopharma Stock (ABUS)?

  • 52 Week High

    $4.73

  • 52 Week Low

    $2.71

What are the historical returns of Arbutus Biopharma (ABUS)?

  • 1 Month Returns

    13.14%

  • 3 Months Returns

    -0.56%

  • 1 Year Returns

    12.42%

  • 5 Years Returns

    91.85%

What is today's market capitalisation of Arbutus Biopharma?

Today's market capitalisation of Arbutus Biopharma ABUS is 670.3M

Who is the Chief Executive Officer (CEO) of Arbutus Biopharma ?

Ms. Lindsay Androski J.D., M.B.A. is the current Chief Executive Officer (CEO) of Arbutus Biopharma.